nodes	percent_of_prediction	percent_of_DWPC	metapath
Trifluridine—Nucleic Acid Synthesis Inhibitors—Gemcitabine—kidney cancer	0.286	0.5	CiPCiCtD
Trifluridine—Nucleic Acid Synthesis Inhibitors—Capecitabine—kidney cancer	0.286	0.5	CiPCiCtD
Trifluridine—TYMP—Capecitabine—kidney cancer	0.142	0.526	CbGbCtD
Trifluridine—Decitabine—Gemcitabine—kidney cancer	0.128	1	CrCrCtD
Trifluridine—TYMS—Capecitabine—kidney cancer	0.0754	0.28	CbGbCtD
Trifluridine—TYMS—Gemcitabine—kidney cancer	0.0523	0.194	CbGbCtD
Trifluridine—TK1—Fluoropyrimidine Activity—PPAT—kidney cancer	0.00199	0.0817	CbGpPWpGaD
Trifluridine—TYMP—Fluoropyrimidine Activity—PPAT—kidney cancer	0.00138	0.0566	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—TFE3—kidney cancer	0.0011	0.0451	CbGpPWpGaD
Trifluridine—TK1—Nucleotide metabolism—PPAT—kidney cancer	0.001	0.041	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—DAPK1—kidney cancer	0.000935	0.0384	CbGpPWpGaD
Trifluridine—TK1—Nucleotide metabolism—APRT—kidney cancer	0.00093	0.0382	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—FOSL1—kidney cancer	0.000723	0.0296	CbGpPWpGaD
Trifluridine—TYMS—Fluoropyrimidine Activity—PPAT—kidney cancer	0.000706	0.029	CbGpPWpGaD
Trifluridine—TYMP—Nucleotide metabolism—PPAT—kidney cancer	0.000694	0.0284	CbGpPWpGaD
Trifluridine—TYMP—Nucleotide metabolism—APRT—kidney cancer	0.000645	0.0264	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—HLTF—kidney cancer	0.000619	0.0254	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—APAF1—kidney cancer	0.000594	0.0244	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—HSPD1—kidney cancer	0.000558	0.0229	CbGpPWpGaD
Trifluridine—Eyelid oedema—Pazopanib—kidney cancer	0.000452	0.128	CcSEcCtD
Trifluridine—TYMS—E2F transcription factor network—TFE3—kidney cancer	0.00039	0.016	CbGpPWpGaD
Trifluridine—TYMS—Docetaxel—Paclitaxel—kidney cancer	0.000384	0.232	CbGdCrCtD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—SLC2A1—kidney cancer	0.000382	0.0157	CbGpPWpGaD
Trifluridine—Eyelid oedema—Everolimus—kidney cancer	0.000357	0.101	CcSEcCtD
Trifluridine—TYMS—Nucleotide metabolism—PPAT—kidney cancer	0.000355	0.0146	CbGpPWpGaD
Trifluridine—TYMS—Nucleotide metabolism—APRT—kidney cancer	0.00033	0.0135	CbGpPWpGaD
Trifluridine—Punctate keratitis—Capecitabine—kidney cancer	0.000329	0.0932	CcSEcCtD
Trifluridine—TYMP—Bladder Cancer—BRAF—kidney cancer	0.0003	0.0123	CbGpPWpGaD
Trifluridine—Eyelid oedema—Sunitinib—kidney cancer	0.000298	0.0846	CcSEcCtD
Trifluridine—TYMP—Bladder Cancer—CDH1—kidney cancer	0.000293	0.012	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—BIRC5—kidney cancer	0.000267	0.0109	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—CDKN2A—kidney cancer	0.000259	0.0106	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—ERBB2—kidney cancer	0.000248	0.0102	CbGpPWpGaD
Trifluridine—TK1—Azacitidine—Gemcitabine—kidney cancer	0.000233	0.141	CbGdCrCtD
Trifluridine—TYMP—Bladder Cancer—CCND1—kidney cancer	0.000219	0.00897	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—APAF1—kidney cancer	0.000211	0.00864	CbGpPWpGaD
Trifluridine—TK1—Fluoropyrimidine Activity—TP53—kidney cancer	0.000198	0.00811	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—VEGFA—kidney cancer	0.000191	0.00782	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—CDKN2A—kidney cancer	0.000188	0.00772	CbGpPWpGaD
Trifluridine—TYMS—Sirolimus—Temsirolimus—kidney cancer	0.000184	0.111	CbGdCrCtD
Trifluridine—TYMS—Sirolimus—Everolimus—kidney cancer	0.000184	0.111	CbGdCrCtD
Trifluridine—TYMS—Gefitinib—Erlotinib—kidney cancer	0.000184	0.111	CbGdCrCtD
Trifluridine—TYMP—Bladder Cancer—MYC—kidney cancer	0.000175	0.00719	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—MAPK1—kidney cancer	0.000172	0.00704	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—CDKN1B—kidney cancer	0.000167	0.00684	CbGpPWpGaD
Trifluridine—Dry eye—Erlotinib—kidney cancer	0.000161	0.0456	CcSEcCtD
Trifluridine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC5A3—kidney cancer	0.000153	0.00628	CbGpPWpGaD
Trifluridine—TYMP—Bladder Cancer—TP53—kidney cancer	0.000144	0.00591	CbGpPWpGaD
Trifluridine—TYMP—Fluoropyrimidine Activity—TP53—kidney cancer	0.000137	0.00562	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ACY1—kidney cancer	0.000131	0.00538	CbGpPWpGaD
Trifluridine—TK1—E2F transcription factor network—MYC—kidney cancer	0.000128	0.00523	CbGpPWpGaD
Trifluridine—TYMS—Vinorelbine—Vinblastine—kidney cancer	0.000123	0.0744	CbGdCrCtD
Trifluridine—TYMS—Vinorelbine—Vincristine—kidney cancer	0.000123	0.0744	CbGdCrCtD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—MYC—kidney cancer	0.00012	0.00491	CbGpPWpGaD
Trifluridine—TYMS—G1/S Transition—PSMD7—kidney cancer	0.000116	0.00475	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PDHB—kidney cancer	0.000112	0.00457	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—SYNE2—kidney cancer	0.000108	0.00444	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—HNF1B—kidney cancer	0.000107	0.0044	CbGpPWpGaD
Trifluridine—TYMS—Vincristine—Vinblastine—kidney cancer	0.000105	0.0636	CbGdCrCtD
Trifluridine—TK1—Metabolism—CCBL1—kidney cancer	0.000105	0.0043	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—KCNMA1—kidney cancer	0.000104	0.00429	CbGpPWpGaD
Trifluridine—TK1—Validated targets of C-MYC transcriptional activation—TP53—kidney cancer	9.83e-05	0.00403	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—PSMD7—kidney cancer	9.77e-05	0.00401	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—APAF1—kidney cancer	9.76e-05	0.004	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—JUND—kidney cancer	9.76e-05	0.004	CbGpPWpGaD
Trifluridine—Vision blurred—Pazopanib—kidney cancer	9.4e-05	0.0267	CcSEcCtD
Trifluridine—TYMS—Circadian rythm related genes—JUND—kidney cancer	9.37e-05	0.00384	CbGpPWpGaD
Trifluridine—Dry eye—Paclitaxel—kidney cancer	9.34e-05	0.0265	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—WT1—kidney cancer	9.26e-05	0.0038	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GLIPR1—kidney cancer	9.09e-05	0.00373	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PPAT—kidney cancer	9.09e-05	0.00373	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ACY1—kidney cancer	9.09e-05	0.00373	CbGpPWpGaD
Trifluridine—TYMS—Vinblastine—Vincristine—kidney cancer	8.47e-05	0.0511	CbGdCrCtD
Trifluridine—TK1—Metabolism—APRT—kidney cancer	8.45e-05	0.00347	CbGpPWpGaD
Trifluridine—TK1—Metabolism—FH—kidney cancer	8.45e-05	0.00347	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ACHE—kidney cancer	8.05e-05	0.0033	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GPC3—kidney cancer	7.95e-05	0.00326	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PDHB—kidney cancer	7.73e-05	0.00317	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CA2—kidney cancer	7.73e-05	0.00317	CbGpPWpGaD
Trifluridine—Dry eye—Capecitabine—kidney cancer	7.67e-05	0.0217	CcSEcCtD
Trifluridine—TK1—Metabolism—ALAD—kidney cancer	7.53e-05	0.00309	CbGpPWpGaD
Trifluridine—Vision blurred—Everolimus—kidney cancer	7.43e-05	0.0211	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ANXA1—kidney cancer	7.4e-05	0.00303	CbGpPWpGaD
Trifluridine—Pain—Temsirolimus—kidney cancer	7.39e-05	0.021	CcSEcCtD
Trifluridine—TK1—Metabolism—ST3GAL2—kidney cancer	7.35e-05	0.00302	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CCBL1—kidney cancer	7.27e-05	0.00298	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ALDH1A1—kidney cancer	7.19e-05	0.00295	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN2B—kidney cancer	7.14e-05	0.00293	CbGpPWpGaD
Trifluridine—TYMS—Fluoropyrimidine Activity—TP53—kidney cancer	7.01e-05	0.00288	CbGpPWpGaD
Trifluridine—Pain—Pazopanib—kidney cancer	6.96e-05	0.0198	CcSEcCtD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC5A3—kidney cancer	6.95e-05	0.00285	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PGK1—kidney cancer	6.89e-05	0.00283	CbGpPWpGaD
Trifluridine—TK1—Metabolism—SLC5A3—kidney cancer	6.89e-05	0.00283	CbGpPWpGaD
Trifluridine—TK1—Metabolism—LDHB—kidney cancer	6.76e-05	0.00277	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDKN2A—kidney cancer	6.67e-05	0.00274	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—JUNB—kidney cancer	6.64e-05	0.00272	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PAK1—kidney cancer	6.64e-05	0.00272	CbGpPWpGaD
Trifluridine—Stinging—Doxorubicin—kidney cancer	6.6e-05	0.0187	CcSEcCtD
Trifluridine—Hypersensitivity—Temsirolimus—kidney cancer	6.37e-05	0.0181	CcSEcCtD
Trifluridine—TYMP—Metabolism—GLIPR1—kidney cancer	6.3e-05	0.00258	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PPAT—kidney cancer	6.3e-05	0.00258	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—EGR1—kidney cancer	6.21e-05	0.00255	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—RYR1—kidney cancer	6.15e-05	0.00252	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—EGR1—kidney cancer	5.96e-05	0.00245	CbGpPWpGaD
Trifluridine—TYMS—E2F transcription factor network—CDKN1B—kidney cancer	5.91e-05	0.00242	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—FH—kidney cancer	5.86e-05	0.0024	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CA9—kidney cancer	5.86e-05	0.0024	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—APRT—kidney cancer	5.86e-05	0.0024	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—RAF1—kidney cancer	5.61e-05	0.0023	CbGpPWpGaD
Trifluridine—Pain—Vinblastine—kidney cancer	5.52e-05	0.0157	CcSEcCtD
Trifluridine—TYMP—Metabolism—GPC3—kidney cancer	5.51e-05	0.00226	CbGpPWpGaD
Trifluridine—Pain—Everolimus—kidney cancer	5.5e-05	0.0156	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—BRCA2—kidney cancer	5.45e-05	0.00224	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN2B—kidney cancer	5.41e-05	0.00222	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CA2—kidney cancer	5.36e-05	0.0022	CbGpPWpGaD
Trifluridine—Pain—Erlotinib—kidney cancer	5.31e-05	0.0151	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ABCB1—kidney cancer	5.28e-05	0.00217	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ALAD—kidney cancer	5.22e-05	0.00214	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CDKN1B—kidney cancer	5.14e-05	0.00211	CbGpPWpGaD
Trifluridine—Nausea—Temsirolimus—kidney cancer	5.13e-05	0.0146	CcSEcCtD
Trifluridine—TYMP—Metabolism—ST3GAL2—kidney cancer	5.1e-05	0.00209	CbGpPWpGaD
Trifluridine—TK1—Metabolism—CRABP1—kidney cancer	4.98e-05	0.00204	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ALDH1A1—kidney cancer	4.98e-05	0.00204	CbGpPWpGaD
Trifluridine—TYMS—Azacitidine—Gemcitabine—kidney cancer	4.96e-05	0.03	CbGdCrCtD
Trifluridine—Dry eye—Doxorubicin—kidney cancer	4.94e-05	0.014	CcSEcCtD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—CCND1—kidney cancer	4.9e-05	0.00201	CbGpPWpGaD
Trifluridine—Nausea—Pazopanib—kidney cancer	4.84e-05	0.0137	CcSEcCtD
Trifluridine—TYMP—Metabolism—PGK1—kidney cancer	4.78e-05	0.00196	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SLC5A3—kidney cancer	4.78e-05	0.00196	CbGpPWpGaD
Trifluridine—Pain—Sorafenib—kidney cancer	4.77e-05	0.0135	CcSEcCtD
Trifluridine—Hypersensitivity—Vinblastine—kidney cancer	4.76e-05	0.0135	CcSEcCtD
Trifluridine—Hypersensitivity—Everolimus—kidney cancer	4.74e-05	0.0134	CcSEcCtD
Trifluridine—TYMP—Metabolism—LDHB—kidney cancer	4.68e-05	0.00192	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ACY1—kidney cancer	4.65e-05	0.00191	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ITPR2—kidney cancer	4.63e-05	0.0019	CbGpPWpGaD
Trifluridine—Pain—Sunitinib—kidney cancer	4.59e-05	0.013	CcSEcCtD
Trifluridine—TYMS—E2F transcription factor network—MYC—kidney cancer	4.52e-05	0.00185	CbGpPWpGaD
Trifluridine—Pain—Dactinomycin—kidney cancer	4.35e-05	0.0123	CcSEcCtD
Trifluridine—TYMS—G1/S Transition—CDKN1B—kidney cancer	4.29e-05	0.00176	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ACHE—kidney cancer	4.22e-05	0.00173	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GSTT1—kidney cancer	4.22e-05	0.00173	CbGpPWpGaD
Trifluridine—Vision blurred—Paclitaxel—kidney cancer	4.17e-05	0.0118	CcSEcCtD
Trifluridine—Hypersensitivity—Sorafenib—kidney cancer	4.11e-05	0.0117	CcSEcCtD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN2A—kidney cancer	4.08e-05	0.00167	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CA9—kidney cancer	4.06e-05	0.00167	CbGpPWpGaD
Trifluridine—TK1—Metabolism—SCARB1—kidney cancer	4e-05	0.00164	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PTGS1—kidney cancer	3.96e-05	0.00162	CbGpPWpGaD
Trifluridine—Hypersensitivity—Sunitinib—kidney cancer	3.96e-05	0.0112	CcSEcCtD
Trifluridine—TYMS—Metabolism—PDHB—kidney cancer	3.95e-05	0.00162	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—MYC—kidney cancer	3.93e-05	0.00161	CbGpPWpGaD
Trifluridine—Pain—Vincristine—kidney cancer	3.88e-05	0.011	CcSEcCtD
Trifluridine—TK1—Metabolism—PSMD7—kidney cancer	3.88e-05	0.00159	CbGpPWpGaD
Trifluridine—Nausea—Vinblastine—kidney cancer	3.83e-05	0.0109	CcSEcCtD
Trifluridine—Nausea—Everolimus—kidney cancer	3.82e-05	0.0108	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—APC—kidney cancer	3.81e-05	0.00156	CbGpPWpGaD
Trifluridine—Hypersensitivity—Dactinomycin—kidney cancer	3.75e-05	0.0106	CcSEcCtD
Trifluridine—TYMS—Metabolism—CCBL1—kidney cancer	3.72e-05	0.00152	CbGpPWpGaD
Trifluridine—Pain—Gemcitabine—kidney cancer	3.69e-05	0.0105	CcSEcCtD
Trifluridine—Nausea—Erlotinib—kidney cancer	3.69e-05	0.0105	CcSEcCtD
Trifluridine—TK1—Metabolism—BCHE—kidney cancer	3.68e-05	0.00151	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC5A5—kidney cancer	3.67e-05	0.0015	CbGpPWpGaD
Trifluridine—TK1—Metabolism—SLC5A5—kidney cancer	3.63e-05	0.00149	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CDKN1B—kidney cancer	3.61e-05	0.00148	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—PSMD7—kidney cancer	3.58e-05	0.00147	CbGpPWpGaD
Trifluridine—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—kidney cancer	3.54e-05	0.00145	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—ANXA2—kidney cancer	3.53e-05	0.00145	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC5A3—kidney cancer	3.53e-05	0.00145	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—ATP7B—kidney cancer	3.53e-05	0.00145	CbGpPWpGaD
Trifluridine—TK1—Metabolism—SLC2A1—kidney cancer	3.51e-05	0.00144	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—AURKA—kidney cancer	3.48e-05	0.00143	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CRABP1—kidney cancer	3.45e-05	0.00142	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—CCND1—kidney cancer	3.45e-05	0.00141	CbGpPWpGaD
Trifluridine—Vision blurred—Capecitabine—kidney cancer	3.42e-05	0.0097	CcSEcCtD
Trifluridine—Hypersensitivity—Vincristine—kidney cancer	3.35e-05	0.0095	CcSEcCtD
Trifluridine—Nausea—Sorafenib—kidney cancer	3.32e-05	0.00941	CcSEcCtD
Trifluridine—TYMS—G1/S Transition—MYC—kidney cancer	3.28e-05	0.00135	CbGpPWpGaD
Trifluridine—TYMS—Retinoblastoma (RB) in Cancer—TP53—kidney cancer	3.23e-05	0.00132	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GLIPR1—kidney cancer	3.22e-05	0.00132	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PPAT—kidney cancer	3.22e-05	0.00132	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ITPR2—kidney cancer	3.21e-05	0.00132	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—PSMD7—kidney cancer	3.2e-05	0.00131	CbGpPWpGaD
Trifluridine—Nausea—Sunitinib—kidney cancer	3.19e-05	0.00905	CcSEcCtD
Trifluridine—TYMS—Cell Cycle—AURKA—kidney cancer	3.12e-05	0.00128	CbGpPWpGaD
Trifluridine—Pain—Paclitaxel—kidney cancer	3.09e-05	0.00875	CcSEcCtD
Trifluridine—Nausea—Dactinomycin—kidney cancer	3.02e-05	0.00857	CcSEcCtD
Trifluridine—TYMS—Metabolism—FH—kidney cancer	3e-05	0.00123	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—APRT—kidney cancer	3e-05	0.00123	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—RAF1—kidney cancer	2.99e-05	0.00123	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—ERBB2—kidney cancer	2.96e-05	0.00121	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GSTT1—kidney cancer	2.93e-05	0.0012	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ACHE—kidney cancer	2.93e-05	0.0012	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GSTP1—kidney cancer	2.93e-05	0.0012	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PTGS2—kidney cancer	2.89e-05	0.00119	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GPC3—kidney cancer	2.82e-05	0.00116	CbGpPWpGaD
Trifluridine—TK1—Metabolism—ABCB1—kidney cancer	2.77e-05	0.00114	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SCARB1—kidney cancer	2.77e-05	0.00114	CbGpPWpGaD
Trifluridine—TYMS—Mitotic G1-G1/S phases—MYC—kidney cancer	2.77e-05	0.00113	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PTGS1—kidney cancer	2.74e-05	0.00112	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CA2—kidney cancer	2.74e-05	0.00112	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CDKN1B—kidney cancer	2.74e-05	0.00112	CbGpPWpGaD
Trifluridine—Nausea—Vincristine—kidney cancer	2.7e-05	0.00766	CcSEcCtD
Trifluridine—TYMP—Metabolism—PSMD7—kidney cancer	2.69e-05	0.0011	CbGpPWpGaD
Trifluridine—TK1—Metabolism—GSTM1—kidney cancer	2.69e-05	0.0011	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ALAD—kidney cancer	2.67e-05	0.0011	CbGpPWpGaD
Trifluridine—Hypersensitivity—Paclitaxel—kidney cancer	2.66e-05	0.00754	CcSEcCtD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN2B—kidney cancer	2.62e-05	0.00107	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CCND1—kidney cancer	2.61e-05	0.00107	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ST3GAL2—kidney cancer	2.61e-05	0.00107	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—JUN—kidney cancer	2.61e-05	0.00107	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—CTNNB1—kidney cancer	2.59e-05	0.00106	CbGpPWpGaD
Trifluridine—Nausea—Gemcitabine—kidney cancer	2.56e-05	0.00726	CcSEcCtD
Trifluridine—TK1—Metabolism—CYP1A1—kidney cancer	2.55e-05	0.00105	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—BCHE—kidney cancer	2.55e-05	0.00105	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ALDH1A1—kidney cancer	2.55e-05	0.00104	CbGpPWpGaD
Trifluridine—Pain—Capecitabine—kidney cancer	2.53e-05	0.00718	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PTEN—kidney cancer	2.52e-05	0.00103	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SLC5A5—kidney cancer	2.52e-05	0.00103	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—JUN—kidney cancer	2.5e-05	0.00103	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SLC5A3—kidney cancer	2.44e-05	0.001	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PGK1—kidney cancer	2.44e-05	0.001	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—SLC2A1—kidney cancer	2.43e-05	0.000998	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—PTEN—kidney cancer	2.42e-05	0.000993	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—LDHB—kidney cancer	2.4e-05	0.000982	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—BRCA2—kidney cancer	2.36e-05	0.000968	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN2B—kidney cancer	2.34e-05	0.00096	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	2.28e-05	0.000934	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—BIRC5—kidney cancer	2.26e-05	0.000926	CbGpPWpGaD
Trifluridine—Vision blurred—Doxorubicin—kidney cancer	2.2e-05	0.00625	CcSEcCtD
Trifluridine—Hypersensitivity—Capecitabine—kidney cancer	2.18e-05	0.00619	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	2.15e-05	0.000884	CbGpPWpGaD
Trifluridine—Nausea—Paclitaxel—kidney cancer	2.14e-05	0.00608	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	2.1e-05	0.000859	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CA9—kidney cancer	2.08e-05	0.000852	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	2.05e-05	0.000841	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GSTP1—kidney cancer	2.03e-05	0.000832	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—BIRC5—kidney cancer	2.02e-05	0.000828	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	1.94e-05	0.000794	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—ABCB1—kidney cancer	1.92e-05	0.000788	CbGpPWpGaD
Trifluridine—TK1—Metabolism—POMC—kidney cancer	1.9e-05	0.00078	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—GSTM1—kidney cancer	1.86e-05	0.000765	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC5A5—kidney cancer	1.86e-05	0.000764	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—SLC2A1—kidney cancer	1.8e-05	0.000738	CbGpPWpGaD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	1.78e-05	0.000729	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—CYP1A1—kidney cancer	1.77e-05	0.000725	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CRABP1—kidney cancer	1.77e-05	0.000724	CbGpPWpGaD
Trifluridine—Nausea—Capecitabine—kidney cancer	1.76e-05	0.00499	CcSEcCtD
Trifluridine—TYMS—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	1.72e-05	0.000706	CbGpPWpGaD
Trifluridine—TYMS—Circadian rythm related genes—TP53—kidney cancer	1.65e-05	0.000677	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ITPR2—kidney cancer	1.64e-05	0.000673	CbGpPWpGaD
Trifluridine—Pain—Doxorubicin—kidney cancer	1.63e-05	0.00463	CcSEcCtD
Trifluridine—TK1—Metabolism—PTGS2—kidney cancer	1.52e-05	0.000622	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ACHE—kidney cancer	1.5e-05	0.000614	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTT1—kidney cancer	1.5e-05	0.000614	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN2A—kidney cancer	1.5e-05	0.000614	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—ABCB1—kidney cancer	1.42e-05	0.000583	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SCARB1—kidney cancer	1.42e-05	0.000581	CbGpPWpGaD
Trifluridine—Hypersensitivity—Doxorubicin—kidney cancer	1.41e-05	0.00399	CcSEcCtD
Trifluridine—TYMS—Metabolism—PTGS1—kidney cancer	1.4e-05	0.000575	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PSMD7—kidney cancer	1.38e-05	0.000564	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN2A—kidney cancer	1.34e-05	0.000549	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CDKN1B—kidney cancer	1.33e-05	0.000544	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PTEN—kidney cancer	1.32e-05	0.000542	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—POMC—kidney cancer	1.32e-05	0.00054	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—BCHE—kidney cancer	1.3e-05	0.000535	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SLC5A5—kidney cancer	1.29e-05	0.000528	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—CCND1—kidney cancer	1.26e-05	0.000519	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—SLC2A1—kidney cancer	1.24e-05	0.00051	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—CDKN1B—kidney cancer	1.19e-05	0.000486	CbGpPWpGaD
Trifluridine—Nausea—Doxorubicin—kidney cancer	1.13e-05	0.00322	CcSEcCtD
Trifluridine—TYMS—Cell Cycle—CCND1—kidney cancer	1.13e-05	0.000464	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PTGS2—kidney cancer	1.05e-05	0.000431	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MAPK3—kidney cancer	1.04e-05	0.000428	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTP1—kidney cancer	1.04e-05	0.000426	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MYC—kidney cancer	1.01e-05	0.000416	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle, Mitotic—MAPK1—kidney cancer	9.92e-06	0.000407	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—ABCB1—kidney cancer	9.82e-06	0.000403	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—GSTM1—kidney cancer	9.54e-06	0.000391	CbGpPWpGaD
Trifluridine—TK1—Metabolism—PIK3CA—kidney cancer	9.33e-06	0.000383	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MAPK3—kidney cancer	9.33e-06	0.000382	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PTEN—kidney cancer	9.17e-06	0.000376	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MYC—kidney cancer	9.07e-06	0.000372	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—CYP1A1—kidney cancer	9.04e-06	0.000371	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—MAPK1—kidney cancer	8.87e-06	0.000364	CbGpPWpGaD
Trifluridine—SLC22A6—Transmembrane transport of small molecules—RAF1—kidney cancer	8.04e-06	0.00033	CbGpPWpGaD
Trifluridine—TYMS—Cell Cycle—TP53—kidney cancer	7.45e-06	0.000305	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—POMC—kidney cancer	6.74e-06	0.000276	CbGpPWpGaD
Trifluridine—TYMP—Metabolism—PIK3CA—kidney cancer	6.47e-06	0.000265	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PTGS2—kidney cancer	5.38e-06	0.000221	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PTEN—kidney cancer	4.69e-06	0.000192	CbGpPWpGaD
Trifluridine—TYMS—Metabolism—PIK3CA—kidney cancer	3.31e-06	0.000136	CbGpPWpGaD
